Literature DB >> 29931030

Gene Editing as a Potential Therapeutic Solution for Fuchs Endothelial Corneal Dystrophy: The Future Is Clearer.

Angela Y Zhu1, Vinod Jaskula-Ranga2, Albert S Jun1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29931030     DOI： 10.1001/jamaophthalmol.2018.2324

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  3 in total

Review 1.  Fuchs endothelial corneal dystrophy and corneal endothelial diseases: East meets West.

Authors:  Y Q Soh; Viridiana Kocaba; Mauricio Pinto; Jodhbir S Mehta
Journal:  Eye (Lond)       Date:  2019-07-02       Impact factor: 3.775

Review 2.  Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis.

Authors:  Stephan Ong Tone; Viridiana Kocaba; Myriam Böhm; Adam Wylegala; Tomas L White; Ula V Jurkunas
Journal:  Prog Retin Eye Res       Date:  2020-05-08       Impact factor: 21.198

3.  Trinucleotide Repeat-Targeting dCas9 as a Therapeutic Strategy for Fuchs' Endothelial Corneal Dystrophy.

Authors:  Ziye Rong; Xin Gong; John D Hulleman; David R Corey; V Vinod Mootha
Journal:  Transl Vis Sci Technol       Date:  2020-08-31       Impact factor: 3.283
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.